<div><p>Swiss drug maker Novartis AG on Tuesday reported a 54 percent rise in fourth-quarter net profit to $2.32 billion on strong sales and favorable exchange rates, and announced the appointment of Joe Jimenez as its new chief executive.</p><p>Earnings per share rose 53 percent to $1.01 ...

<div><p>BASEL, Switzerland (Reuters) - Novartis AG handed drugs head Joe Jimenez its top job on Tuesday with a mission to guide the Swiss drugmaker through ever-increasing competition to its key medicines.</p><p>The chatty 50-year-old American steps up after just over two years running Novartis's dominant drugs unit and ...